首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   9425篇
  免费   853篇
  国内免费   40篇
耳鼻咽喉   118篇
儿科学   301篇
妇产科学   175篇
基础医学   1336篇
口腔科学   250篇
临床医学   958篇
内科学   2209篇
皮肤病学   236篇
神经病学   906篇
特种医学   224篇
外国民族医学   2篇
外科学   1187篇
综合类   76篇
一般理论   1篇
预防医学   846篇
眼科学   166篇
药学   572篇
中国医学   23篇
肿瘤学   732篇
  2023年   66篇
  2022年   53篇
  2021年   325篇
  2020年   136篇
  2019年   339篇
  2018年   371篇
  2017年   263篇
  2016年   251篇
  2015年   284篇
  2014年   335篇
  2013年   476篇
  2012年   589篇
  2011年   600篇
  2010年   358篇
  2009年   290篇
  2008年   473篇
  2007年   499篇
  2006年   487篇
  2005年   446篇
  2004年   380篇
  2003年   363篇
  2002年   370篇
  2001年   183篇
  2000年   202篇
  1999年   185篇
  1998年   90篇
  1997年   80篇
  1996年   68篇
  1995年   65篇
  1994年   53篇
  1993年   45篇
  1992年   147篇
  1991年   158篇
  1990年   131篇
  1989年   134篇
  1988年   122篇
  1987年   104篇
  1986年   113篇
  1985年   79篇
  1984年   71篇
  1983年   57篇
  1982年   25篇
  1981年   31篇
  1980年   29篇
  1979年   52篇
  1977年   31篇
  1976年   30篇
  1973年   37篇
  1970年   24篇
  1969年   26篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Ana Lopez Alonso 《Platelets》2015,26(4):317-323
Abstract

While the interactions between Gram-positive bacteria and platelets have been well characterized, there is a paucity of data on the interaction between other pathogens and platelets. However, thrombocytopenia is a common feature with many infections especially viral hemorrhagic fever. The little available data on these interactions indicate a similarity with bacteria-platelet interactions with receptors such as FcγRIIa and Toll-Like Receptors (TLR) playing key roles with many pathogens. This review summarizes the known interactions between platelets and pathogens such as viruses, fungi and parasites.  相似文献   
2.
3.
4.
5.
In the work described here, our aim was to determine, in an elderly population, changes in muscle thickness (MT), cross-sectional area (CSA) and echo intensity (EI) of the quadriceps muscles at four time points (0, 5, 10 and 15 min; i.e., T0, T5, T10 and T15, respectively) after changing from a standing to supine position. Twenty-one elderly participants (14 men: 68.1 ± 4.6 y; 8 women: 66.8 ± 4.1 y) were evaluated at four time points. Rectus femoris CSA (RFCSA), MT and EI of the quadriceps femoris (QF) muscles were assessed. EI significantly increased from T0 to T5, T10 and T15 (p < 0.001), whereas no differences were observed between T5 and T15 in the rectus femoris (RFEI), vastus intermedius (VIEI) and quadriceps femoris (QFEI). No differences were observed between any time points in the RFCSA and MT of QF muscles. In summary, these results suggest that periods >5 min are not necessary to obtain consistent MT and EI measurements of quadriceps femoris muscles in the elderly population.  相似文献   
6.

Background

The ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) phase 3 clinical trials showed that the adjuvanted recombinant zoster vaccine (RZV) was ≥90% efficacious in preventing herpes zoster in adults. Here we present a comprehensive overview of the safety data from these studies.

Methods

Adults aged ≥50 (ZOE-50) and ≥70 (ZOE-70) years were randomly vaccinated with RZV or placebo. Safety analyses were performed on the pooled total vaccinated cohort, consisting of participants receiving at least one dose of RZV or placebo. Solicited and unsolicited adverse events (AEs) were collected for 7 and 30?days after each vaccination, respectively. Serious AEs (SAEs) were collected from the first vaccination until 12?months post-last dose. Fatal AEs, vaccination-related SAEs, and potential immune-mediated diseases (pIMDs) were collected during the entire study period.

Results

Safety was evaluated in 14,645 RZV and 14,660 placebo recipients. More RZV than placebo recipients reported unsolicited AEs (50.5% versus 32.0%); the difference was driven by transient injection site and solicited systemic reactions that were generally seen in the first week post-vaccination. The occurrence of overall SAEs (RZV: 10.1%; Placebo: 10.4%), fatal AEs (RZV: 4.3%; Placebo: 4.6%), and pIMDs (RZV: 1.2%; Placebo: 1.4%) was balanced between groups. The occurrence of possible exacerbations of pIMDs was rare and similar between groups. Overall, except for the expected local and systemic symptoms, the safety results were comparable between the RZV and Placebo groups irrespective of participant age, gender, or race.

Conclusions

No safety concerns arose, supporting the favorable benefit-risk profile of RZV.  相似文献   
7.
8.
9.
10.
Cultures of performativity may contribute to organizational and individual arrogance. Workplace organizations have individuals who at various times will display arrogance, which may manifest in behaviours, such as an exaggerated sense of self-importance, dismissiveness of others, condescending behaviors and an impatient manner. Arrogance is not a flattering label and irrespective of the reason or the position of power, in the context of organizational behaviors, may not be useful and may even be detrimental to the work environment. Thus, it is timely to reflect on the implications of arrogance in the workplace. Advocacy and empowerment can be undermined and relationships adversely impacted, including the achievement of positive consumer outcomes. This paper provides an introduction to arrogance, and then discusses arrogance to promote awareness of the potential consequences of arrogance and its constituent behaviors.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号